BioSig Technologies Issues Shareholder Letter for 2017
21 déc. 2017 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Dec. 21, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission
14 nov. 2017 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 14, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
IP veteran Andrew Filler joins BioSig Technologies’ Board of Directors
10 nov. 2017 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 10, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies to Speak at Digital Silver Forum in Helsinki, Finland on November 28
08 nov. 2017 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 08, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies Partners with Sherpa Technology Group
02 nov. 2017 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 02, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
BioSig Technologies Announces Results of Independent Product Assessment Study for PURE EP System
26 oct. 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 26, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
BioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards Commercialization
24 oct. 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 24, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
BioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022
19 oct. 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 19, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need within...
BioSig Technologies to Present at the Dawson James Small Cap Growth Conference
13 oct. 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 13, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
Telemedicine Technology Joint Venture Announced Between Cytta Corp and Cardiocomm Solutions
12 oct. 2017 07h30 HE
|
Cytta Corp.
Palm Desert, CA, Oct. 12, 2017 (GLOBE NEWSWIRE) -- Cytta Corp. (OTCPINK:CYCA), a leading provider of mobile smartphone and web based healthcare technology solutions, and CardioComm Solutions, Inc....